Upregulation of protein S by progestins

Journal of Thrombosis and Haemostasis

Volumn 5, Issue 11, 2007, Pages 2243-2249

  Hughes, Quintin ^a,b,d   Watson, M ^a   Cole, V ^a   Sayer, M ^a   Baker, R ^a,c   Staton, J ^a  

^a ROYAL PERTH HOSPITAL   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^d NONE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; GESTAGEN; MEDROXYPROGESTERONE; MIFEPRISTONE; PROGESTERONE; PROGESTERONE RECEPTOR B; PROTEIN PROS1; PROTEIN S; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; ESTROGEN RESPONSIVE ELEMENT; FEMALE; HORMONAL CONTRACEPTION; HUMAN; HUMAN CELL; IN VITRO STUDY; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN ANALYSIS; PROTEIN DETERMINATION; PROTEIN DNA INTERACTION; PROTEIN EXPRESSION; TRANSCRIPTION REGULATION;

CELL LINE, TUMOR; CONTRACEPTIVES, ORAL; HUMANS; PROGESTERONE; PROGESTINS; PROMOTER REGIONS (GENETICS); PROTEIN ISOFORMS; PROTEIN S; RECEPTORS, PROGESTERONE; RESPONSE ELEMENTS; TRANSCRIPTION, GENETIC; UP-REGULATION;

EID: 35448972982     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2007.02730.x     Document Type: Article

References (26)

1. Walker FJ. Regulation of activated protein C by a new protein. A possible function for bovine protein S. J Biol Chem 1980; 255: 5521-4.
2. Rosing J, Hoekema L, Nicolaes GA, Thomassen MC, Hemker HC, Varadi K, Schwarz HP, Tans G. Effects of protein S and factor Xa on peptide bond cleavages during inactivation of factor Va and factor VaR506Q by activated protein C. J Biol Chem 1995; 270: 27852-8.
3. O'Brien LM, Mastri M, Fay PJ. Regulation of factor VIIIa by human activated protein C and protein S: Inactivation of cofactor in the intrinsic factor Xase. Blood 2000; 95: 1714-20.
4. Hackeng TM, Sere KM, Tans G, Rosing J. Protein S stimulates inhibition of the tissue factor pathway by tissue factor pathway inhibitor. Proc Natl Acad Sci U S A 2006; 103: 3106-11.
5. Mahasandana C, Suvatte V, Chuansumrit A, Marlar RA, Manco-Johnson MJ, Jacobson LJ, Hathaway WE. Homozygous protein S deficiency in an infant with purpura fulminans. J Pediatr 1990; 117: 750-3.
6. Mahasandana C, Suvatte V, Marlar RA, Manco-Johnson MJ, Jacobson LJ, Hathaway WE. Neonatal purpura fulminans associated with homozygous protein S deficiency. Lancet 1990; 335: 61-2.
7. Gruselle P, Ooghe P, Cauchie P, Van der Cruyssen G. Severe thrombophilic diathesis starting with hepatic vein thrombosis (BUDD-CHIARI syndrome) in a family with a new Protein S gene mutation. Acta Gastroenterol Belg 2006; 69: 20-4.
8. Comp PC, Thurnau GR, Welsh J, Esmon CT. Functional and immunologic protein S levels are decreased during pregnancy. Blood 1986; 68: 881-5.
9. Malm J, Laurell M, Dahlback B. Changes in the plasma levels of vitamin K-dependent proteins C and S and of C4b-binding protein during pregnancy and oral contraception. Br J Haematol 1988; 68: 437-43.
10. Oruc S, Saruc M, Koyuncu FM, Ozdemir E. Changes in the plasma activities of protein C and protein S during pregnancy. Aust N Z J Obstet Gynaecol 2000; 40: 448-50.
11. Uchikova EH, Ledjev II. Changes in haemostasis during normal pregnancy. Eur J Obstet Gynecol Reprod Biol 2005; 119: 185-8.
12. Tans G, Curvers J, Middeldorp S, Thomassen MC, Meijers JC, Prins MH, Bouma BN, Buller HR, Rosing J. A randomized cross-over study on the effects of levonorgestrel- and desogestrel-containing oral contraceptives on the anticoagulant pathways. Thromb Haemost 2000; 84: 15-21.
13. Mackie IJ, Piegsa K, Furs SA, Johnson J, Bounds W, Machin SJ, Guillebaud J. Protein S levels are lower in women receiving desogestrel-containing combined oral contraceptives (COCs) than in women receiving levonorgestrel-containing COCs at steady state and on cross-over. Br J Haematol 2001; 113: 898-904.
14. Kemmeren JM, Algra A, Meijers JC, Tans G, Bouma BN, Curvers J, Rosing J, Grobbee DE. Effect of second- and third-generation oral contraceptives on the protein C system in the absence or presence of the factor VLeiden mutation: A randomized trial. Blood 2004; 103: 927-33.
15. Mirkin S, Wong BC, Archer DF. Effects of 17beta-estradiol, progesterone, synthetic progestins, tibolone, and raloxifene on vascular endothelial growth factor and Thrombospondin-1 messenger RNA in breast cancer cells. Int J Gynecol Cancer 2006; 16 (Suppl. 2): 560-3.
16. Zerr-Fouineau M, Chataigneau M, Blot C, Schini-Kerth VB. Progestins overcome inhibition of platelet aggregation by endothelial cells by down-regulating endothelial NO synthase via glucocorticoid receptors. FASEB J 2007; 21: 265-73.
17. Connaghan-Jones KD, Heneghan AF, Miura MT, Bain DL. Thermodynamic analysis of progesterone receptor-promoter interactions reveals a molecular model for isoform-specific function. Proc Natl Acad Sci U S A 2007; 104: 2187-92.
18. Graham JD, Clarke CL. Expression and transcriptional activity of progesterone receptor A and progesterone receptor B in mammalian cells. Breast Cancer Res 2002; 4: 187-90.
19. Tatewaki H, Tsuda H, Kanaji T, Yokoyama K, Hamasaki N. Characterization of the human protein S gene promoter: A possible role of transcription factors Sp1 and HNF3 in liver. Thromb Haemost 2003; 90: 1029-39.
20. de Wolf CJ, Cupers RM, Bertina RM, Vos HL. The constitutive expression of anticoagulant protein S is regulated through multiple binding sites for Sp1 and Sp3 transcription factors in the protein S gene promoter. J Biol Chem 2006; 281: 17635-43.
21. de Wolf CJ, Cupers RM, Bertina RM, Vos HL. Interleukin-6 induction of protein s is regulated through signal transducer and activator of transcription 3. Arterioscler Thromb Vasc Biol 2006; 26: 2168-74.
22. Espinosa-Parrilla Y, Morell M, Borrell M, Souto JC, Fontcuberta J, Estivill X, Sala N. Optimization of a simple and rapid single-strand conformation analysis for detection of mutations in the PROS1 gene: identification of seven novel mutations and three novel, apparently neutral, variants. Hum Mutat 2000; 15: 463-73.
23. Middeldorp S. Oral contraceptives and the risk of venous thromboembolism. Gend Med 2005; 2 (Suppl. A): S3-9.
24. Tseng L, Tang M, Wang Z, Mazella J. Progesterone receptor (hPR) upregulates the fibronectin promoter activity in human decidual fibroblasts. DNA Cell Biol 2003; 22: 633-40.
25. Yie SM, Xiao R, Librach CL. Progesterone regulates HLA-G gene expression through a novel progesterone response element. Hum Reprod 2006; 21: 2538-44.
26. Kozak M. An analysis of 5′-noncoding sequences from 699 vertebrate messenger RNAs. Nucleic Acids Res 1987; 15: 8125-48.